companies making glp 1 resistant foods Why food makers aren't afraid of GLP-1 drugs GLP-1 Food Brand Strategy: 7

In the withdrawal trial, participants switched to placebo regained about 14% over the following year. Tapering, at least 1.2 g/kg of protein, resistance training, and follow-up reduce the risk, but no post-stop protocol guarantees maintenance

This observation, while encouraging, must be interpreted with caution: the absence of evidence of side effects is not evidence of absence

This article is exclusive to STAT+ subscribers Unlock this article and get additional analysis of the technologies disrupting health care by subscribing to STAT+

Six studies were on-going and their full reports were not available, or had not published, or an author had retired

The product is intended only for use by persons with appropriate knowledge and experience in working with materials of this class